ZNO
Director Trades
| Date | Director | Value |
|---|---|---|
| 5/8/25 | P. Hyslop | $522,238 |
| 5/8/25 | D. Clarke | $2,531 |
| 5/8/25 | E. Hansen | $2,503 |
Company News
Zoono and OSY partner with Sharpak to tackle global food waste through packaging innovation
Zoono Group (ASX: ZNO) and partner OSY have signed an exclusive contract with Sharpak Aylesham, progressing their participation in the global effort to solve a major food waste issue. Sharpak, the UK division of a leading European manufacturer of packaging solutions for the food industry, has agreed to use Zoono’s shelf-life extension products and OSY’s […]
Zoono reveals prosperous April driven by mounting demand for sanitisers
Antimicrobial hand and surface sanitiser company Zoono (ASX: ZNO) has impressed investors yet again, with news its business-to-business sales had exceeded NZ$11 million (A$10.34 million) for April – boosted by increasing uptake in the UK and Europe. New Zealand-headquartered Zoono noted the sales figures did not include online consumer sales which had been closed for […]
Zoono surface sanitiser proves 99.99% effective against coronavirus
Laboratory tests conducted by Zoono Group (ASX: ZNO) on its Z-71 Microbe Shield surface sanitiser have confirmed the product to be more than 99.99% effective against feline coronavirus, a surrogate of COVID-19. While the virus has been shown to survive on surfaces for up to nine days, Z-71 was successfully tested against a variety of […]
Zoono inks sanitiser deal with Johns Lyng Group
Biotech company Zoono Group (ASX: ZNO) has clinched an exclusive deal with Australian builder Johns Lyng Group (ASX: JLG) for the distribution of sanitisers that have tested 99.99% effective against a COVID-19 surrogate virus. The exclusive distribution agreement will make Johns Lyng’s New South Wales-based building remediation subsidiary, RestorX Australia, an exclusive distributor for Zoono […]
Zoono and Eagle Health prepare for co-branded response to ongoing Coronavirus pandemic
Zoono Group (ASX: ZNO) has signed an agreement with Eagle Health (ASX: EHH) to distribute co-branded antimicrobial products and offline retail sales in China to help the country combat the coronavirus outbreak. Zoono sells a range of antimicrobial products using purified, deionized water and a proprietary “quaternary ammonium antimicrobial compound”. The move is a response to […]
Zoono shares soar as world races to shield against coronavirus
Antimicrobial company Zoono Group (ASX: ZNO) is one of a few biotech stocks appearing to benefit from the latest outbreak of coronavirus, now being named COVID-19, with its shares surging dramatically and deals snapping up pronto. The New Zealand business develops, manufactures and distributes a suite of antimicrobial products including hand and surface sanitisers that […]
Zoono signs distribution deal to supply antimicrobial products to Chinese markets
Global biotech company Zoono Group (ASX: ZNO) has signed a five-year distribution agreement with Beijing Youmeng Technology and Development Limited for the supply of antimicrobial skin and surface sprays to China’s childcare and hotel sectors. Following last month’s outbreak of novel coronavirus 2019-nCoV, Zoono said there has been “unprecedented interest” in its technology given its […]
Zoono ramps up production in anticipation its antimicrobial sanitisers can destroy coronavirus
As the coronavirus unfolds worldwide, antimicrobial product producer Zoono Group (ASX: ZNO) revealed its confidence in being part of the solution in preventing the spread of the virus and potential new virus threats. After being inundated with public and shareholder enquiries, Zoono stated its Z71 Microbe Shield surface sanitiser was successfully tested in 2014 against […]
Zoono to sell swine flu treatment in China
Biotech company Zoono (ASX: ZNO) is setting up a distribution company to sell its products including swine flu treatments to farmers, food producers and processors in China. The move follows six months of trials across several animal health industry sectors and will be a joint collaboration with a group of leaders in the Chinese agribusiness/veterinarian […]
Zoono delivers an effective tool in response to growing African swine fever epidemic
Biotech company Zoono (ASX: ZNO) has announced that its proprietary microbe shield, ZOONO Z71, was found to be “extremely effective” in counteracting the African Swine Fever (ASF) virus. In research conducted at the Wageningen Bio-Veterinary Research Department of Virology in Lelystad, Netherlands, researchers discovered that Zoono’s Z71 microbe shield inactivated the ASF virus with 99.99% efficiency […]